Custom Assays Market Size, Share, Trends, Growth and Forecast 2032

What is the Custom Assays Market Size?

According to the report published by Zion Market Research, the global Custom Assays Market size was valued at USD 3.18 Billion in 2023 and is predicted to reach USD 6.05 Billion by the end of 2032. The market is expected to grow with a CAGR of 7.4% during the forecast period. The report analyzes the global Custom Assays Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Custom Assays industry.

Request Free Sample

Global Custom Assays Market: Overview

The custom assay is designed cell or biochemical based assays which are provided by the assay kits manufacturers to their customers when requested in order to fulfill their needs and purposes. Custom assay helps in providing easy solutions to the industrial and academic laboratories for quantitative and qualitative determination of different biological analytes such as proteins, antibodies, enzymes, antigens, biomarkers, etc. The services provided by custom assay are significantly beneficial to the biotechnology industries for HLA tissue typing, genotyping, etc. Customized assays that are based on the cell are used in government institutes, cancer research institutes, forensics, etc. Custom assays are also utilized in the food industries and pharmaceutical sectors for quality testing.

Global Custom Assays Market: Segmentation

The global custom assays market is segmented into assay type, technology, and retail end user.

On the basis of the assay type, the global market is segregated into activity assays, ELISA assays, screening assays, conjugation assay, competitive assays, sandwich assays, and others.

Depending on the technology, the market is categorized into flow cytometry, suspension/ bead-based assays, membrane based/ planar assays, and others.

On the basis of the retail end user, the market is fragmented into academic and research institutes, biotechnology companies, contract research organizations, life science industries, diagnostic centers, and food and beverage companies.

Request Free Sample

Global Custom Assays Market: Growth Factors

The factors that will drive the custom assays market are the rise in the number of research and academic institutes and the increasing activities of research and development in the biotechnology and life science. Moreover, growing demand for cell-based diagnostics and tissue diagnostic for the diseases such as HIV, cancer, and infectious diseases is anticipated to fuel the global custom assay products in the coming years. The accessibility of custom assay and mass purchase contracts for a large number of screening of biological samples proves cost effective for biotechnological industries. The emergence of the biochip technology will open good opportunities for the service providers in the global market.

Custom Assays Market: Report Scope

Global Custom Assays Market: Regional Analysis

The geographical segmentation of the global custom assays market is diversified into North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific, and the Middle East and Africa. The market in the Asia-Pacific region will grow at a significant rate owing to the increasing number of research institutes that has emerged in the countries such as Australia, India, and Japan. The region that holds the largest market share in the global custom assays market is the North America. The factor attributing to this market growth is most of the popular research and academic organizations are present in the US. North America is followed by Europe. The market growth in the European regions is owing to the presence of a huge number of market players in this region.

Global Custom Assays Market: Competitive Players

The key market players that are involved in the custom assays market include:

• Bioassay Systems
• Thermo Fisher Scientific Inc.
• Fluidigm
• F. Hoffmann-La Roche AG
• Quansys Bioscience
• Promega Corporation
• Sigma-Aldrich Inc.
• R & D Systems Inc.
• Luminex Corporation
• Qiagen N.V.
• BD Biosciences, and others.

The Global Custom Assays Market is segmented as follows:

By Assay type 

• activity assays
• ELISA assays 
• screening assays
• conjugation assay
• competitive assays 
• sandwich assays 
• and others 

By Technology 

• flow cytometry
• suspension/ bead-based assays
• membrane based/ planar assays 
• and others

By retail end user 

• academic and research institutes
• biotechnology companies 
• contract research organizations
• life science industries
• diagnostic centers
• food and beverage companies

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.